NVCR - HC Wainwright cuts NovoCure to neutral in wake of failed study
2023-08-29 16:27:46 ET
More on NovoCure
- NovoCure: TTFields' Ovarian Trial Short-Circuits (Rating Downgrade)
- NovoCure Limited: Record Losses, Falling Margins, And Downward Momentum
- NovoCure: Uncertain Regulatory Path And Slowing Growth
- NovoCure Limited ( NVCR ) Q2 2023 Earnings Call Transcript
- Novocure falls after setback to Phase 3 trial for Tumor Treating Fields
- NovoCure upgraded at Piper Sandler ahead of Phase 3 readout for TTFieds
- NovoCure upgraded at Wedbush citing balanced risk-reward setup
- Why did NovoCure stock crash today? TTFields data
- Seeking Alpha’s Quant Rating on NovoCure
- Earnings data for NovoCure
For further details see:
HC Wainwright cuts NovoCure to neutral in wake of failed study